microdosing glp 1 for hashimoto's GLP-1 Microdosing GLP-1 for Weight Loss

For vascular dementia, no significant difference was observed

Not to mention: the astronomical cost of medical services and medication

Reduction in Risk Across Fourteen Obesity-Related Cancers A large observational study presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025, involving more than 170,000 patients with diabetes and obesity, found that GLP-1 receptor agonists were associated with a modest but statistically meaningful reduction in the incidence of 14 obesity-related cancers , with colorectal cancer demonstrating particularly favourable outcomes when compared to patients receiving DPP-4 inhibitors

In studies with rats and mice, Saxenda and medicines that work like Saxenda caused thyroid tumors, including thyroid cancer

Does stress influence sleep patterns, food intake, weight gain, abdominal obesity and weight loss interventions and vice versa